Peanut allergies are no joke. I know quite a few people who are seriously allergic to peanuts, and the repercussions of an untreated reaction to peanuts can be fatal.
I have good news for those of us who are unable to savor the incredible flavor of peanuts and further peanut butter, though. “The US Food and Drug Administration (FDA) has officially approved the nation’s first treatment for peanut allergies,” says an article from The Good News Network, and “the drug, which is being marketed as Palforzia by biopharmaceutical company Aimmune Therapeutics, is also the first approved therapy for any food allergy.”
The FDA has recently sanctioned the drug to be commercialized and developed, and the drug itself “consists of a powder that is manufactured from peanuts and packaged in pull-apart color-coded capsules for dose escalation and up-dosing. The powder is emptied from the capsules or sachet and mixed with a small amount of semisolid food—such as applesauce, yogurt, or pudding—which the patient then consumes,” says the article.
This particular form of treatment aims to diminish allergic reactions overall, including anaphylaxis, and minimizes the potential of unintentional interaction with peanuts.
As for what the treatment involves, it has three main phases. “Initial Dose Escalation, Up-Dosing, and Maintenance. The Initial Dose Escalation phase is given on a single day. The Up-Dosing phase consists of 11 increasing dose levels and occurs over several months. Initial Dose Escalation, and the first dose of each Up-Dosing level, are administered under supervision of a healthcare professional in a healthcare setting with the ability to manage potentially severe allergic reactions, including anaphylaxis,” the article explains.
It is arguable that this form of treatment will not be successful for everyone who tries it, but for those of us that it could be effective for, I think this is tremendous news.